Matrix metalloproteinase 9 expression in canine mammary carcinomas

Gramulia, Bianca C; Pulz, Lidia H; Mota, Emerson F. F; Fukumasu, Heidge; Strefezzi, Ricardo F.
Braz. J. Vet. Pathol. ; 9(2): 55-61, jul. 2016. ilus, tab
Artículo en Inglés | VETINDEX | ID: vti-684133

Documentos relacionados

  1. Matrix metalloproteinase 9 expression in canine mammary carcinomas
  2. Canine Mammary Carcinoma With Vacuolated Cytoplasm: Glycogen-Rich Carcinoma, a Histological Type Distinct From Lipid-Rich Carcinoma.
  3. Solitary and multiple simultaneous malignant epithelial mammary tumours in dogs: An explorative retrospective study.
  4. Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.
  5. Association of mast cell density, microvascular density and endothelial area with clinicopathological parameters and prognosis in canine mammary gland carcinomas.
  6. Circulating microRNA as biomarkers of canine mammary carcinoma in dogs.
  7. Identification of EDIL3 biomarkers as a biomarker and potential therapeutic target of canine mammary carcinomas based on integrated bioinformatics analysis.
  8. Neutrophil-to-lymphocyte ratio is an independent prognostic marker for feline mammary carcinomas.
  9. Application of shear wave elastography in the diagnosis of mammary gland neoplasm in dogs.
  10. YRNA and tRNA fragments can differentiate benign from malignant canine mammary gland tumors.